Study endpoints
gastric cancer
GASTRIC CANCER
The primary endpoint was the % reduction in LBM at POD7. This primary endpoint was selected, because the previous clinical trial comparing oral immunonutrition in total gastrectomy for gastric cancer had remarkable difference of LBM at POD7 between institutes that used BCAA-contaning regimens and those did not use them [